WO2000049144A3 - Proteines fixatrices pyk2 - Google Patents
Proteines fixatrices pyk2 Download PDFInfo
- Publication number
- WO2000049144A3 WO2000049144A3 PCT/US2000/004647 US0004647W WO0049144A3 WO 2000049144 A3 WO2000049144 A3 WO 2000049144A3 US 0004647 W US0004647 W US 0004647W WO 0049144 A3 WO0049144 A3 WO 0049144A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pyk2 binding
- binding proteins
- pyk2
- protein
- novel
- Prior art date
Links
- 102000014914 Carrier Proteins Human genes 0.000 title abstract 5
- 101150094745 Ptk2b gene Proteins 0.000 title abstract 5
- 108091008324 binding proteins Proteins 0.000 title abstract 5
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 102000001253 Protein Kinase Human genes 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108060006633 protein kinase Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU32422/00A AU3242200A (en) | 1999-02-22 | 2000-02-18 | Pyk2 binding proteins |
CA002362943A CA2362943A1 (fr) | 1999-02-22 | 2000-02-18 | Proteines fixatrices pyk2 |
JP2000599869A JP2003510010A (ja) | 1999-02-22 | 2000-02-18 | Pyk2結合蛋白質 |
EP00910308A EP1157104A2 (fr) | 1999-02-22 | 2000-02-18 | Proteines fixatrices pyk2 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12112599P | 1999-02-22 | 1999-02-22 | |
US60/121,125 | 1999-02-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000049144A2 WO2000049144A2 (fr) | 2000-08-24 |
WO2000049144A3 true WO2000049144A3 (fr) | 2001-02-15 |
Family
ID=22394720
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/004647 WO2000049144A2 (fr) | 1999-02-22 | 2000-02-18 | Proteines fixatrices pyk2 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1157104A2 (fr) |
JP (1) | JP2003510010A (fr) |
AU (1) | AU3242200A (fr) |
CA (1) | CA2362943A1 (fr) |
WO (1) | WO2000049144A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050059621A1 (en) * | 2003-06-06 | 2005-03-17 | Irene Griswold-Prenner | Methods for using modulators of proline-rich tyrosine kinase 2 |
US7977462B2 (en) * | 2007-04-19 | 2011-07-12 | Cell Signaling Technology, Inc. | Tyrosine phosphorylation sites |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007870A1 (fr) * | 1996-08-23 | 1998-02-26 | Beth Israel Deaconess Medical Center, Inc. | Nouvelles molecules de signalisation raftk et leurs utilisations |
WO1998016639A1 (fr) * | 1996-10-11 | 1998-04-23 | Sugen, Inc. | Proteines rdgb |
WO1998026054A2 (fr) * | 1996-12-11 | 1998-06-18 | Sugen, Inc. | Produits et procedes en relation avec la pyk2 |
WO1998036065A1 (fr) * | 1997-02-14 | 1998-08-20 | Dana-Farber Cancer Institute | Facteurs de stimulation de la differentiation et utilisations de ces facteurs |
-
2000
- 2000-02-18 CA CA002362943A patent/CA2362943A1/fr not_active Abandoned
- 2000-02-18 WO PCT/US2000/004647 patent/WO2000049144A2/fr not_active Application Discontinuation
- 2000-02-18 EP EP00910308A patent/EP1157104A2/fr not_active Withdrawn
- 2000-02-18 AU AU32422/00A patent/AU3242200A/en not_active Abandoned
- 2000-02-18 JP JP2000599869A patent/JP2003510010A/ja not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998007870A1 (fr) * | 1996-08-23 | 1998-02-26 | Beth Israel Deaconess Medical Center, Inc. | Nouvelles molecules de signalisation raftk et leurs utilisations |
WO1998016639A1 (fr) * | 1996-10-11 | 1998-04-23 | Sugen, Inc. | Proteines rdgb |
WO1998026054A2 (fr) * | 1996-12-11 | 1998-06-18 | Sugen, Inc. | Produits et procedes en relation avec la pyk2 |
WO1998036065A1 (fr) * | 1997-02-14 | 1998-08-20 | Dana-Farber Cancer Institute | Facteurs de stimulation de la differentiation et utilisations de ces facteurs |
Non-Patent Citations (7)
Title |
---|
ANDREEV J ET AL.: "Identification of a new Pyk2 target protein with Arf-GAP activity", MOLECULAR AND CELLULAR BIOLOGY, vol. 19, no. 3, March 1999 (1999-03-01), pages 2338 - 2350, XP002145146 * |
BROWN M T ET AL.: "Regulation, substrates and functions of src", BIOCHIMICA ET BIOPHYSICA ACTA, vol. 1287, no. 2-3, 7 June 1996 (1996-06-07), pages 121 - 149, XP000938413 * |
DATABASE TREMBL EMBL; 1 June 1998 (1998-06-01), ISHIKAWA K ET AL.: "KIAA0400", XP002145148 * |
ISHIKAWA K ET AL.: "Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro", DNA RESEARCH, vol. 4, no. 5, 31 October 1997 (1997-10-31), pages 307 - 313, XP002066665 * |
LEV S ET AL.: "Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein", MOLECULAR AND CELLULAR BIOLOGY, vol. 19, no. 3, March 1999 (1999-03-01), pages 2278 - 2288, XP002145147 * |
SCHLAEPFER D D ET AL.: "Integrin signalling and tyrosine phosphorylation: just the FAKs?", TRENDS IN CELL BIOLOGY, vol. 8, no. 4, April 1998 (1998-04-01), pages 151 - 157, XP000938480 * |
WENG Z ET AL.: "Identification of Src, Fyn, and Lyn SH3-binding proteins: Implications for a function of SH3 domains", MOLECULAR AND CELLULAR BIOLOGY, vol. 14, no. 7, 1 July 1994 (1994-07-01), pages 4509 - 4521, XP000652941 * |
Also Published As
Publication number | Publication date |
---|---|
CA2362943A1 (fr) | 2000-08-24 |
AU3242200A (en) | 2000-09-04 |
WO2000049144A2 (fr) | 2000-08-24 |
EP1157104A2 (fr) | 2001-11-28 |
JP2003510010A (ja) | 2003-03-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005000200A3 (fr) | Nouvelles kinases | |
EP0837131A3 (fr) | Composé contenant la protéine liant la fibronectine obtenu à partir de Staphylococcus | |
WO2004006838A3 (fr) | Nouvelles kinases | |
WO2000073469A3 (fr) | Proteines kinases | |
WO2000031235A3 (fr) | Sequences nucleotidiques et proteiques de gene nogo et procedes reposant sur ces sequences | |
WO2001038503A3 (fr) | Nouvelles proteines kinases humaines et enzymes analogues | |
WO2001083782A3 (fr) | Nouvelles proteases | |
WO1996034953A3 (fr) | Variants de cd16-ii | |
WO1998014596A3 (fr) | Tyrosine phosphatases proteiques associees a des maladies | |
WO1997008314A3 (fr) | Facteur de liaison telomerique, son utilisation diagnostique et therapeutique | |
WO1995025171A3 (fr) | Sequences d'adn pour metalloproteases matricielles, leur production et leur utilisation | |
WO2001046394A3 (fr) | Proteines phosphatases mammiferes | |
WO1998006841A3 (fr) | Deux proteines humaines du genre nsp | |
WO2001066594A3 (fr) | Nouvelles proteines kinases humaines et enzymes analogues de proteines kinases | |
WO1998011232A3 (fr) | Proteine humaine de type nm23 | |
WO2004096856A3 (fr) | Famille de proteines secretees | |
WO2000049144A3 (fr) | Proteines fixatrices pyk2 | |
WO1999066051A3 (fr) | Kinases en rapport avec nek et avec bub1 | |
WO2004096976A3 (fr) | Compositions de composes exprimes par la rate (spex) et leurs procedes d'utilisation | |
WO2000047723A3 (fr) | Nouvelles proteines | |
WO1998031805A3 (fr) | Proteines humaines se liant au zinc | |
WO2001036478A3 (fr) | Methodes et compositions se rapportant a des polypeptides et a des polynucleotides similaires au facteur bactericide augmentant la permeabilite | |
WO1998004585A3 (fr) | Nouvel antigene macrophage humain | |
WO2001092491A3 (fr) | Phosphatases de proteine de mammifere | |
WO1997040134A3 (fr) | Dnase ii humaine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
ENP | Entry into the national phase |
Ref document number: 2362943 Country of ref document: CA Ref country code: CA Ref document number: 2362943 Kind code of ref document: A Format of ref document f/p: F |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 599869 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000910308 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2000910308 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000910308 Country of ref document: EP |